Tech Company Financing Transactions
Complexa Funding Round
Private investors participated in a $11 million funding round for Complexa. The round was announced by the company on 4/17/2019.
Transaction Overview
Company Name
Announced On
4/17/2019
Transaction Type
Venture Equity
Amount
$10,999,999
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 4 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1055 Westlakes Dr. 200
Berwyn, PA 19312
USA
Berwyn, PA 19312
USA
Phone
Website
Email Address
Overview
At Complexa, we're transforming the treatment of severe and life-threatening diseases through scientific innovation. Our pioneering signal mediating technology stems from research by one of the world's leading scientists in the field of biochemistry and pharmacology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Francisco Salva
VP - Finance
David Sinkway
VP - Manufacturing
William Leong
VP - Operations
Michael Nelson
Browse more venture capital transactions:
Prev: 4/17/2019: Bardy Diagnostics venture capital transaction
Next: 4/18/2019: Sisu Global Health venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs